Global Pharmaceutical Excipients Market Growth 2024-2030
Pharmaceutical Excipients, valued at US$ 96.05 billion in 2023, are expected to reach US$ 141.74 billion by 2030, with a 5.7% CAGR driven by growing downstream demand.
- Bonafide Trust
- 04-01-2024
- Pages : 132
- Figures : 88
- Tables : 177
- Region : Global
- Category : Lifescience & Healthcare
- Pharmaceutical
According to Publisher’s latest study, the global Pharmaceutical Excipients market size was valued at US$ 96050 million in 2023. With the growing demand in the downstream market, the Pharmaceutical Excipients are forecast to a readjusted size of US$ 141740 million by 2030 with a CAGR of 5.7% during the review period.
Market Overview
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe research report highlights the growth potential of the global Pharmaceutical Excipients market. Pharmaceutical Excipients are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimisation remain crucial for the widespread adoption of Pharmaceutical Excipients. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalise on the immense opportunities presented by the Pharmaceutical Excipients market.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Key Features:
The report on the Pharmaceutical Excipients market reflects various aspects and provides valuable insights into the industry.
Market Size and Growth: The research report provides an overview of the current size and growth of the Pharmaceutical Excipients market. It may include historical data, market segmentation by Type (e.g., Triglycerides, Mannitol), and regional breakdowns.
Market Drivers: The market for pharmaceutical excipients is being driven by the rising demand for pharmaceutical products and generic medications. The market for pharmaceutical excipients is anticipated to gain from the rising popularity of generic medications. Because they are less expensive than branded medications, generics are anticipated to increase sales volume when they enter the market. The patent cliff has increased the approval of generic drugs. Prominent US-based pharmaceutical companies, including Torrent Pharma, Aurobindo Pharma, Zydus Lifesciences, and Ajanta Pharma, are expected to benefit greatly from this breakthrough.
Excipients can be an important cost-saving strategy for generic medication producers, who are always seeking methods to cut expenses. The pharmaceutical excipient industry is driven by the consequent increase in demand for excipients that are both high-quality and reasonably priced. This is regarded as a sign that the market for pharmaceutical excipients is expanding.
Challenges-Novel excipients come with high development costs. New excipient approval procedures can be drawn out, costly, and complicated. Pharmaceutical businesses may find it more difficult to justify their investment in developing new medicines due to the high capital costs involved and the potential for further delays in the time to market for novel excipients. The FDA and other regulatory bodies must approve new excipients before they may be used in pharmaceutical products. To meet the demands of the pharmaceutical business, these excipients also need to be produced in big quantities. It is anticipated that this procedure, which can be expensive and time-consuming, will limit the market.
Strict Rules and Regulations. The market for pharmaceutical excipients has a lot of challenges because of strict regulatory regulations. Regulations governing the production, testing, and application of excipients have been put in place by regulatory organizations such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). The purpose of these rules is to guarantee the effectiveness and safety of pharmaceuticals. Strict legal constraints, nevertheless, can also make creating and releasing novel excipients onto the market more difficult. Because of this, excipient manufacturers may find it difficult to stay innovative and meet the changing needs of the pharmaceutical sector. The European Medicines Agency's (EMA) regulatory regulations and the strict New Drug Application (NDA) process of the U.S. FDA, for instance, can cause major delays in the release of novel excipients.
Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical Excipients industry. This includes advancements in Pharmaceutical Excipients technology, Pharmaceutical Excipients new entrants, Pharmaceutical Excipients new investment, and other innovations that are shaping the future of Pharmaceutical Excipients.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical Excipients market. It includes factors influencing customers' purchasing decisions, and preferences for Pharmaceutical Excipients products.
Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the Pharmaceutical Excipients market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the Pharmaceutical Excipients market. The report also evaluates the effectiveness of these policies in driving market growth.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the Pharmaceutical Excipients industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The use of functional and multifunctional pharmaceutical excipients is growing. A kind of pharmaceutical excipient known as co-processed multifunctional excipients is produced by physically combining two or more excipients through granulation, blending, or mixing. Through this process, each excipient's physical characteristics are changed, creating a new excipient with improved functionality. These excipients have several advantages over single-function excipients currently on the market. They reduce variability in formulation properties by guaranteeing consistent batch-to-batch performance of pharmaceutical formulations, which opens lucrative opportunities for future market growth. They also improve formulation performance by having superior flowability, compressibility, binding, and disintegrating properties compared to individual excipients.
Recent developments- October 2023 saw the launch of Clariant's portfolio of high-performing pharmaceutical ingredient solutions, a speciality chemicals firm with a focus on sustainability, to aid in the development of safe and effective medications. Additionally, to address issues with active pharmaceutical ingredient (API) distribution and bioavailability, Clariant Health Care increased the variety of functional excipients in its portfolio.
September 20, 2023: Three new excipient grades have been added to Roquette's portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical components. Roquette is a plant-based ingredient provider.
Market Segmentation:
The pharmaceutical Excipients market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. In terms of product type, starch is the largest market segment with a 90% share, and in terms of application, oral formulations have the largest share with about 51%.
1. Segmentation by type
• Triglycerides
• Mannitol
• Sorbitol
• Sucrose
• Dextrose
• Starch
• Others
2. Segmentation by application
• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other
Regional Insights: The market is being dominated by America. It is anticipated that rising R&D spending will accelerate market expansion. Because of the significant presence of important businesses like Dow, Evonik, Croda International Plc, and others, the United States dominates the American region. Because of the constantly expanding pharmaceutical business and the increased manufacture of generic medications, China is the dominant country in the Asia-Pacific area. North America is the world's largest market with a market share of about 36 per cent, followed by Asia Pacific with about 33 per cent and Europe with 28 per cent.
3. Americas
• United States
• Canada
• Mexico
• Brazil
4. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
5. Europe
• Germany
• France
• UK
• Italy
• Russia
6. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries
Competitive Landscape: Major global pharmaceutical excipients players include DowDuPont (FMC), JRS Pharma, BASF, Lubrizol and Ashland. Globally, the top five players have a share of nearly 21 per cent by revenue. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• DowDuPont (FMC)
• JRS Pharma
• BASF
• Lubrizol
• Ashland
• Croda International
• Roquette
• Shin-Etsu
• Evonik
• Associated British Foods
• Südzucker AG
• Cosan S.A.
• Mitr Phol
• Mitsubishi
• Hunan ER-KANG
• Anhui Sun here
• Tianjin Chase Sun
• Xiwang Group
• ShengTai Group
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmaceutical Excipients Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Pharmaceutical Excipients by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Pharmaceutical Excipients by Country/Region, 2019, 2023 & 2030
- 2.2 Pharmaceutical Excipients Segment by Type
- 2.2.1 Triglycerides
- 2.2.2 Mannitol
- 2.2.3 Sorbitol
- 2.2.4 Sucrose
- 2.2.5 Dextrose
- 2.2.6 Starch
- 2.2.7 Others
- 2.3 Pharmaceutical Excipients Sales by Type
- 2.3.1 Global Pharmaceutical Excipients Sales Market Share by Type (2019-2024)
- 2.3.2 Global Pharmaceutical Excipients Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Pharmaceutical Excipients Sale Price by Type (2019-2024)
- 2.4 Pharmaceutical Excipients Segment by Application
- 2.4.1 Oral Formulations
- 2.4.2 Topical Formulations
- 2.4.3 Parenteral Formulations
- 2.4.4 Other
- 2.5 Pharmaceutical Excipients Sales by Application
- 2.5.1 Global Pharmaceutical Excipients Sale Market Share by Application (2019-2024)
- 2.5.2 Global Pharmaceutical Excipients Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Pharmaceutical Excipients Sale Price by Application (2019-2024)
- 3 Global Pharmaceutical Excipients by Company
- 3.1 Global Pharmaceutical Excipients Breakdown Data by Company
- 3.1.1 Global Pharmaceutical Excipients Annual Sales by Company (2019-2024)
- 3.1.2 Global Pharmaceutical Excipients Sales Market Share by Company (2019-2024)
- 3.2 Global Pharmaceutical Excipients Annual Revenue by Company (2019-2024)
- 3.2.1 Global Pharmaceutical Excipients Revenue by Company (2019-2024)
- 3.2.2 Global Pharmaceutical Excipients Revenue Market Share by Company (2019-2024)
- 3.3 Global Pharmaceutical Excipients Sale Price by Company
- 3.4 Key Manufacturers Pharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Pharmaceutical Excipients Product Location Distribution
- 3.4.2 Players Pharmaceutical Excipients Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Pharmaceutical Excipients by Geographic Region
- 4.1 World Historic Pharmaceutical Excipients Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Pharmaceutical Excipients Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Pharmaceutical Excipients Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Pharmaceutical Excipients Market Size by Country/Region (2019-2024)
- 4.2.1 Global Pharmaceutical Excipients Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Pharmaceutical Excipients Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Pharmaceutical Excipients Sales Growth
- 4.4 APAC Pharmaceutical Excipients Sales Growth
- 4.5 Europe Pharmaceutical Excipients Sales Growth
- 4.6 Middle East & Africa Pharmaceutical Excipients Sales Growth
- 5 Americas
- 5.1 Americas Pharmaceutical Excipients Sales by Country
- 5.1.1 Americas Pharmaceutical Excipients Sales by Country (2019-2024)
- 5.1.2 Americas Pharmaceutical Excipients Revenue by Country (2019-2024)
- 5.2 Americas Pharmaceutical Excipients Sales by Type
- 5.3 Americas Pharmaceutical Excipients Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Pharmaceutical Excipients Sales by Region
- 6.1.1 APAC Pharmaceutical Excipients Sales by Region (2019-2024)
- 6.1.2 APAC Pharmaceutical Excipients Revenue by Region (2019-2024)
- 6.2 APAC Pharmaceutical Excipients Sales by Type
- 6.3 APAC Pharmaceutical Excipients Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Pharmaceutical Excipients by Country
- 7.1.1 Europe Pharmaceutical Excipients Sales by Country (2019-2024)
- 7.1.2 Europe Pharmaceutical Excipients Revenue by Country (2019-2024)
- 7.2 Europe Pharmaceutical Excipients Sales by Type
- 7.3 Europe Pharmaceutical Excipients Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Pharmaceutical Excipients by Country
- 8.1.1 Middle East & Africa Pharmaceutical Excipients Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Pharmaceutical Excipients Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Pharmaceutical Excipients Sales by Type
- 8.3 Middle East & Africa Pharmaceutical Excipients Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients
- 10.3 Manufacturing Process Analysis of Pharmaceutical Excipients
- 10.4 Industry Chain Structure of Pharmaceutical Excipients
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Pharmaceutical Excipients Distributors
- 11.3 Pharmaceutical Excipients Customer
- 12 World Forecast Review for Pharmaceutical Excipients by Geographic Region
- 12.1 Global Pharmaceutical Excipients Market Size Forecast by Region
- 12.1.1 Global Pharmaceutical Excipients Forecast by Region (2025-2030)
- 12.1.2 Global Pharmaceutical Excipients Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Pharmaceutical Excipients Forecast by Type
- 12.7 Global Pharmaceutical Excipients Forecast by Application
- 13 Key Players Analysis
- 13.1 DowDuPont (FMC)
- 13.1.1 DowDuPont (FMC) Company Information
- 13.1.2 DowDuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
- 13.1.3 DowDuPont (FMC) Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 DowDuPont (FMC) Main Business Overview
- 13.1.5 DowDuPont (FMC) Latest Developments
- 13.2 JRS Pharma
- 13.2.1 JRS Pharma Company Information
- 13.2.2 JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
- 13.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 JRS Pharma Main Business Overview
- 13.2.5 JRS Pharma Latest Developments
- 13.3 BASF
- 13.3.1 BASF Company Information
- 13.3.2 BASF Pharmaceutical Excipients Product Portfolios and Specifications
- 13.3.3 BASF Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 BASF Main Business Overview
- 13.3.5 BASF Latest Developments
- 13.4 Lubrizol
- 13.4.1 Lubrizol Company Information
- 13.4.2 Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
- 13.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Lubrizol Main Business Overview
- 13.4.5 Lubrizol Latest Developments
- 13.5 Ashland
- 13.5.1 Ashland Company Information
- 13.5.2 Ashland Pharmaceutical Excipients Product Portfolios and Specifications
- 13.5.3 Ashland Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Ashland Main Business Overview
- 13.5.5 Ashland Latest Developments
- 13.6 Croda International
- 13.6.1 Croda International Company Information
- 13.6.2 Croda International Pharmaceutical Excipients Product Portfolios and Specifications
- 13.6.3 Croda International Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Croda International Main Business Overview
- 13.6.5 Croda International Latest Developments
- 13.7 Roquette
- 13.7.1 Roquette Company Information
- 13.7.2 Roquette Pharmaceutical Excipients Product Portfolios and Specifications
- 13.7.3 Roquette Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Roquette Main Business Overview
- 13.7.5 Roquette Latest Developments
- 13.8 Shin-Etsu
- 13.8.1 Shin-Etsu Company Information
- 13.8.2 Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
- 13.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Shin-Etsu Main Business Overview
- 13.8.5 Shin-Etsu Latest Developments
- 13.9 Evonik
- 13.9.1 Evonik Company Information
- 13.9.2 Evonik Pharmaceutical Excipients Product Portfolios and Specifications
- 13.9.3 Evonik Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Evonik Main Business Overview
- 13.9.5 Evonik Latest Developments
- 13.10 Associated British Foods
- 13.10.1 Associated British Foods Company Information
- 13.10.2 Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
- 13.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Associated British Foods Main Business Overview
- 13.10.5 Associated British Foods Latest Developments
- 13.11 Südzucker AG
- 13.11.1 Südzucker AG Company Information
- 13.11.2 Südzucker AG Pharmaceutical Excipients Product Portfolios and Specifications
- 13.11.3 Südzucker AG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Südzucker AG Main Business Overview
- 13.11.5 Südzucker AG Latest Developments
- 13.12 Cosan S.A.
- 13.12.1 Cosan S.A. Company Information
- 13.12.2 Cosan S.A. Pharmaceutical Excipients Product Portfolios and Specifications
- 13.12.3 Cosan S.A. Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Cosan S.A. Main Business Overview
- 13.12.5 Cosan S.A. Latest Developments
- 13.13 Mitr Phol
- 13.13.1 Mitr Phol Company Information
- 13.13.2 Mitr Phol Pharmaceutical Excipients Product Portfolios and Specifications
- 13.13.3 Mitr Phol Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Mitr Phol Main Business Overview
- 13.13.5 Mitr Phol Latest Developments
- 13.14 Mitsubishi
- 13.14.1 Mitsubishi Company Information
- 13.14.2 Mitsubishi Pharmaceutical Excipients Product Portfolios and Specifications
- 13.14.3 Mitsubishi Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Mitsubishi Main Business Overview
- 13.14.5 Mitsubishi Latest Developments
- 13.15 Hunan ER-KANG
- 13.15.1 Hunan ER-KANG Company Information
- 13.15.2 Hunan ER-KANG Pharmaceutical Excipients Product Portfolios and Specifications
- 13.15.3 Hunan ER-KANG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 Hunan ER-KANG Main Business Overview
- 13.15.5 Hunan ER-KANG Latest Developments
- 13.16 Anhui Sunhere
- 13.16.1 Anhui Sunhere Company Information
- 13.16.2 Anhui Sunhere Pharmaceutical Excipients Product Portfolios and Specifications
- 13.16.3 Anhui Sunhere Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.16.4 Anhui Sunhere Main Business Overview
- 13.16.5 Anhui Sunhere Latest Developments
- 13.17 Tianjin Chase Sun
- 13.17.1 Tianjin Chase Sun Company Information
- 13.17.2 Tianjin Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
- 13.17.3 Tianjin Chase Sun Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.17.4 Tianjin Chase Sun Main Business Overview
- 13.17.5 Tianjin Chase Sun Latest Developments
- 13.18 Xiwang Group
- 13.18.1 Xiwang Group Company Information
- 13.18.2 Xiwang Group Pharmaceutical Excipients Product Portfolios and Specifications
- 13.18.3 Xiwang Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.18.4 Xiwang Group Main Business Overview
- 13.18.5 Xiwang Group Latest Developments
- 13.19 ShengTai Group
- 13.19.1 ShengTai Group Company Information
- 13.19.2 ShengTai Group Pharmaceutical Excipients Product Portfolios and Specifications
- 13.19.3 ShengTai Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.19.4 ShengTai Group Main Business Overview
- 13.19.5 ShengTai Group Latest Developments
- 14 Research Findings and Conclusion
List of Tables
Table 1. Pharmaceutical Excipients Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pharmaceutical Excipients Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Triglycerides
Table 4. Major Players of Mannitol
Table 5. Major Players of Sorbitol
Table 6. Major Players of Sucrose
Table 7. Major Players of Dextrose
Table 8. Major Players of Starch
Table 9. Major Players of Others
Table 10. Global Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 11. Global Pharmaceutical Excipients Sales Market Share by Type (2019-2024)
Table 12. Global Pharmaceutical Excipients Revenue by Type (2019-2024) & ($ million)
Table 13. Global Pharmaceutical Excipients Revenue Market Share by Type (2019-2024)
Table 14. Global Pharmaceutical Excipients Sale Price by Type (2019-2024) & (US$/Ton)
Table 15. Global Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 16. Global Pharmaceutical Excipients Sales Market Share by Application (2019-2024)
Table 17. Global Pharmaceutical Excipients Revenue by Application (2019-2024)
Table 18. Global Pharmaceutical Excipients Revenue Market Share by Application (2019-2024)
Table 19. Global Pharmaceutical Excipients Sale Price by Application (2019-2024) & (US$/Ton)
Table 20. Global Pharmaceutical Excipients Sales by Company (2019-2024) & (K Tons)
Table 21. Global Pharmaceutical Excipients Sales Market Share by Company (2019-2024)
Table 22. Global Pharmaceutical Excipients Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Pharmaceutical Excipients Revenue Market Share by Company (2019-2024)
Table 24. Global Pharmaceutical Excipients Sale Price by Company (2019-2024) & (US$/Ton)
Table 25. Key Manufacturers Pharmaceutical Excipients Producing Area Distribution and Sales Area
Table 26. Players Pharmaceutical Excipients Products Offered
Table 27. Pharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pharmaceutical Excipients Sales by Geographic Region (2019-2024) & (K Tons)
Table 31. Global Pharmaceutical Excipients Sales Market Share Geographic Region (2019-2024)
Table 32. Global Pharmaceutical Excipients Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Pharmaceutical Excipients Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Pharmaceutical Excipients Sales by Country/Region (2019-2024) & (K Tons)
Table 35. Global Pharmaceutical Excipients Sales Market Share by Country/Region (2019-2024)
Table 36. Global Pharmaceutical Excipients Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Pharmaceutical Excipients Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 39. Americas Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 40. Americas Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 42. Americas Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 43. Americas Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 44. APAC Pharmaceutical Excipients Sales by Region (2019-2024) & (K Tons)
Table 45. APAC Pharmaceutical Excipients Sales Market Share by Region (2019-2024)
Table 46. APAC Pharmaceutical Excipients Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Pharmaceutical Excipients Revenue Market Share by Region (2019-2024)
Table 48. APAC Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 49. APAC Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 50. Europe Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 51. Europe Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 52. Europe Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 54. Europe Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 55. Europe Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 56. Middle East & Africa Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 57. Middle East & Africa Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 61. Middle East & Africa Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 62. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients
Table 63. Key Market Challenges & Risks of Pharmaceutical Excipients
Table 64. Key Industry Trends of Pharmaceutical Excipients
Table 65. Pharmaceutical Excipients Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Pharmaceutical Excipients Distributors List
Table 68. Pharmaceutical Excipients Customer List
Table 69. Global Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Tons)
Table 70. Global Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 72. Americas Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Tons)
Table 74. APAC Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 76. Europe Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 78. Middle East & Africa Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Pharmaceutical Excipients Sales Forecast by Type (2025-2030) & (K Tons)
Table 80. Global Pharmaceutical Excipients Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Pharmaceutical Excipients Sales Forecast by Application (2025-2030) & (K Tons)
Table 82. Global Pharmaceutical Excipients Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. DowDuPont (FMC) Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 84. DowDuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
Table 85. DowDuPont (FMC) Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 86. DowDuPont (FMC) Main Business
Table 87. DowDuPont (FMC) Latest Developments
Table 88. JRS Pharma Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 89. JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
Table 90. JRS Pharma Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 91. JRS Pharma Main Business
Table 92. JRS Pharma Latest Developments
Table 93. BASF Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 94. BASF Pharmaceutical Excipients Product Portfolios and Specifications
Table 95. BASF Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 96. BASF Main Business
Table 97. BASF Latest Developments
Table 98. Lubrizol Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 99. Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
Table 100. Lubrizol Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 101. Lubrizol Main Business
Table 102. Lubrizol Latest Developments
Table 103. Ashland Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 104. Ashland Pharmaceutical Excipients Product Portfolios and Specifications
Table 105. Ashland Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 106. Ashland Main Business
Table 107. Ashland Latest Developments
Table 108. Croda International Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 109. Croda International Pharmaceutical Excipients Product Portfolios and Specifications
Table 110. Croda International Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 111. Croda International Main Business
Table 112. Croda International Latest Developments
Table 113. Roquette Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 114. Roquette Pharmaceutical Excipients Product Portfolios and Specifications
Table 115. Roquette Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 116. Roquette Main Business
Table 117. Roquette Latest Developments
Table 118. Shin-Etsu Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 119. Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
Table 120. Shin-Etsu Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 121. Shin-Etsu Main Business
Table 122. Shin-Etsu Latest Developments
Table 123. Evonik Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 124. Evonik Pharmaceutical Excipients Product Portfolios and Specifications
Table 125. Evonik Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 126. Evonik Main Business
Table 127. Evonik Latest Developments
Table 128. Associated British Foods Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 129. Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
Table 130. Associated British Foods Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 131. Associated British Foods Main Business
Table 132. Associated British Foods Latest Developments
Table 133. Südzucker AG Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 134. Südzucker AG Pharmaceutical Excipients Product Portfolios and Specifications
Table 135. Südzucker AG Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 136. Südzucker AG Main Business
Table 137. Südzucker AG Latest Developments
Table 138. Cosan S.A. Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 139. Cosan S.A. Pharmaceutical Excipients Product Portfolios and Specifications
Table 140. Cosan S.A. Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 141. Cosan S.A. Main Business
Table 142. Cosan S.A. Latest Developments
Table 143. Mitr Phol Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 144. Mitr Phol Pharmaceutical Excipients Product Portfolios and Specifications
Table 145. Mitr Phol Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 146. Mitr Phol Main Business
Table 147. Mitr Phol Latest Developments
Table 148. Mitsubishi Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 149. Mitsubishi Pharmaceutical Excipients Product Portfolios and Specifications
Table 150. Mitsubishi Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 151. Mitsubishi Main Business
Table 152. Mitsubishi Latest Developments
Table 153. Hunan ER-KANG Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 154. Hunan ER-KANG Pharmaceutical Excipients Product Portfolios and Specifications
Table 155. Hunan ER-KANG Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 156. Hunan ER-KANG Main Business
Table 157. Hunan ER-KANG Latest Developments
Table 158. Anhui Sunhere Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 159. Anhui Sunhere Pharmaceutical Excipients Product Portfolios and Specifications
Table 160. Anhui Sunhere Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 161. Anhui Sunhere Main Business
Table 162. Anhui Sunhere Latest Developments
Table 163. Tianjin Chase Sun Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 164. Tianjin Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
Table 165. Tianjin Chase Sun Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 166. Tianjin Chase Sun Main Business
Table 167. Tianjin Chase Sun Latest Developments
Table 168. Xiwang Group Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 169. Xiwang Group Pharmaceutical Excipients Product Portfolios and Specifications
Table 170. Xiwang Group Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 171. Xiwang Group Main Business
Table 172. Xiwang Group Latest Developments
Table 173. ShengTai Group Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 174. ShengTai Group Pharmaceutical Excipients Product Portfolios and Specifications
Table 175. ShengTai Group Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 176. ShengTai Group Main Business
Table 177. ShengTai Group Latest Developments
Table 1. Pharmaceutical Excipients Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pharmaceutical Excipients Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Triglycerides
Table 4. Major Players of Mannitol
Table 5. Major Players of Sorbitol
Table 6. Major Players of Sucrose
Table 7. Major Players of Dextrose
Table 8. Major Players of Starch
Table 9. Major Players of Others
Table 10. Global Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 11. Global Pharmaceutical Excipients Sales Market Share by Type (2019-2024)
Table 12. Global Pharmaceutical Excipients Revenue by Type (2019-2024) & ($ million)
Table 13. Global Pharmaceutical Excipients Revenue Market Share by Type (2019-2024)
Table 14. Global Pharmaceutical Excipients Sale Price by Type (2019-2024) & (US$/Ton)
Table 15. Global Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 16. Global Pharmaceutical Excipients Sales Market Share by Application (2019-2024)
Table 17. Global Pharmaceutical Excipients Revenue by Application (2019-2024)
Table 18. Global Pharmaceutical Excipients Revenue Market Share by Application (2019-2024)
Table 19. Global Pharmaceutical Excipients Sale Price by Application (2019-2024) & (US$/Ton)
Table 20. Global Pharmaceutical Excipients Sales by Company (2019-2024) & (K Tons)
Table 21. Global Pharmaceutical Excipients Sales Market Share by Company (2019-2024)
Table 22. Global Pharmaceutical Excipients Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Pharmaceutical Excipients Revenue Market Share by Company (2019-2024)
Table 24. Global Pharmaceutical Excipients Sale Price by Company (2019-2024) & (US$/Ton)
Table 25. Key Manufacturers Pharmaceutical Excipients Producing Area Distribution and Sales Area
Table 26. Players Pharmaceutical Excipients Products Offered
Table 27. Pharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pharmaceutical Excipients Sales by Geographic Region (2019-2024) & (K Tons)
Table 31. Global Pharmaceutical Excipients Sales Market Share Geographic Region (2019-2024)
Table 32. Global Pharmaceutical Excipients Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Pharmaceutical Excipients Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Pharmaceutical Excipients Sales by Country/Region (2019-2024) & (K Tons)
Table 35. Global Pharmaceutical Excipients Sales Market Share by Country/Region (2019-2024)
Table 36. Global Pharmaceutical Excipients Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Pharmaceutical Excipients Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 39. Americas Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 40. Americas Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 42. Americas Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 43. Americas Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 44. APAC Pharmaceutical Excipients Sales by Region (2019-2024) & (K Tons)
Table 45. APAC Pharmaceutical Excipients Sales Market Share by Region (2019-2024)
Table 46. APAC Pharmaceutical Excipients Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Pharmaceutical Excipients Revenue Market Share by Region (2019-2024)
Table 48. APAC Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 49. APAC Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 50. Europe Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 51. Europe Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 52. Europe Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 54. Europe Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 55. Europe Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 56. Middle East & Africa Pharmaceutical Excipients Sales by Country (2019-2024) & (K Tons)
Table 57. Middle East & Africa Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Pharmaceutical Excipients Sales by Type (2019-2024) & (K Tons)
Table 61. Middle East & Africa Pharmaceutical Excipients Sales by Application (2019-2024) & (K Tons)
Table 62. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients
Table 63. Key Market Challenges & Risks of Pharmaceutical Excipients
Table 64. Key Industry Trends of Pharmaceutical Excipients
Table 65. Pharmaceutical Excipients Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Pharmaceutical Excipients Distributors List
Table 68. Pharmaceutical Excipients Customer List
Table 69. Global Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Tons)
Table 70. Global Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 72. Americas Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Tons)
Table 74. APAC Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 76. Europe Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Tons)
Table 78. Middle East & Africa Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Pharmaceutical Excipients Sales Forecast by Type (2025-2030) & (K Tons)
Table 80. Global Pharmaceutical Excipients Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Pharmaceutical Excipients Sales Forecast by Application (2025-2030) & (K Tons)
Table 82. Global Pharmaceutical Excipients Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. DowDuPont (FMC) Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 84. DowDuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
Table 85. DowDuPont (FMC) Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 86. DowDuPont (FMC) Main Business
Table 87. DowDuPont (FMC) Latest Developments
Table 88. JRS Pharma Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 89. JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
Table 90. JRS Pharma Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 91. JRS Pharma Main Business
Table 92. JRS Pharma Latest Developments
Table 93. BASF Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 94. BASF Pharmaceutical Excipients Product Portfolios and Specifications
Table 95. BASF Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 96. BASF Main Business
Table 97. BASF Latest Developments
Table 98. Lubrizol Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 99. Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
Table 100. Lubrizol Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 101. Lubrizol Main Business
Table 102. Lubrizol Latest Developments
Table 103. Ashland Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 104. Ashland Pharmaceutical Excipients Product Portfolios and Specifications
Table 105. Ashland Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 106. Ashland Main Business
Table 107. Ashland Latest Developments
Table 108. Croda International Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 109. Croda International Pharmaceutical Excipients Product Portfolios and Specifications
Table 110. Croda International Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 111. Croda International Main Business
Table 112. Croda International Latest Developments
Table 113. Roquette Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 114. Roquette Pharmaceutical Excipients Product Portfolios and Specifications
Table 115. Roquette Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 116. Roquette Main Business
Table 117. Roquette Latest Developments
Table 118. Shin-Etsu Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 119. Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
Table 120. Shin-Etsu Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 121. Shin-Etsu Main Business
Table 122. Shin-Etsu Latest Developments
Table 123. Evonik Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 124. Evonik Pharmaceutical Excipients Product Portfolios and Specifications
Table 125. Evonik Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 126. Evonik Main Business
Table 127. Evonik Latest Developments
Table 128. Associated British Foods Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 129. Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
Table 130. Associated British Foods Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 131. Associated British Foods Main Business
Table 132. Associated British Foods Latest Developments
Table 133. Südzucker AG Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 134. Südzucker AG Pharmaceutical Excipients Product Portfolios and Specifications
Table 135. Südzucker AG Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 136. Südzucker AG Main Business
Table 137. Südzucker AG Latest Developments
Table 138. Cosan S.A. Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 139. Cosan S.A. Pharmaceutical Excipients Product Portfolios and Specifications
Table 140. Cosan S.A. Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 141. Cosan S.A. Main Business
Table 142. Cosan S.A. Latest Developments
Table 143. Mitr Phol Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 144. Mitr Phol Pharmaceutical Excipients Product Portfolios and Specifications
Table 145. Mitr Phol Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 146. Mitr Phol Main Business
Table 147. Mitr Phol Latest Developments
Table 148. Mitsubishi Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 149. Mitsubishi Pharmaceutical Excipients Product Portfolios and Specifications
Table 150. Mitsubishi Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 151. Mitsubishi Main Business
Table 152. Mitsubishi Latest Developments
Table 153. Hunan ER-KANG Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 154. Hunan ER-KANG Pharmaceutical Excipients Product Portfolios and Specifications
Table 155. Hunan ER-KANG Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 156. Hunan ER-KANG Main Business
Table 157. Hunan ER-KANG Latest Developments
Table 158. Anhui Sunhere Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 159. Anhui Sunhere Pharmaceutical Excipients Product Portfolios and Specifications
Table 160. Anhui Sunhere Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 161. Anhui Sunhere Main Business
Table 162. Anhui Sunhere Latest Developments
Table 163. Tianjin Chase Sun Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 164. Tianjin Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
Table 165. Tianjin Chase Sun Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 166. Tianjin Chase Sun Main Business
Table 167. Tianjin Chase Sun Latest Developments
Table 168. Xiwang Group Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 169. Xiwang Group Pharmaceutical Excipients Product Portfolios and Specifications
Table 170. Xiwang Group Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 171. Xiwang Group Main Business
Table 172. Xiwang Group Latest Developments
Table 173. ShengTai Group Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 174. ShengTai Group Pharmaceutical Excipients Product Portfolios and Specifications
Table 175. ShengTai Group Pharmaceutical Excipients Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 176. ShengTai Group Main Business
Table 177. ShengTai Group Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (01 May, 2026)
- Notify To Team (01 May, 2026)
- Report updation (02 May, 2026)
- Report Quality Check (02 May, 2026)
- Report Dispatch (03 May, 2026)
- Hard Copy
Recently Viewed Products
Global Pharmaceutical Excipients Market Growth 2024-2030
We are friendly and approachable, give us a call.